Market Insight

Markets rarely move at random. InvestorPlace’s leading analysts break down macro trends, sector dynamics, and recurring market patterns to help investors understand what is changing, what matters most, and where opportunities may emerge.

Priceline Slashed Its Outlook, But PCLN Stock Will Recover

By Dan Burrows, InvestorPlace Feature Writer
Priceline spooked the market, but compelling valuation and technical support should arrest the slide in PCLN stock soon.

Should You Buy PayPal Stock? 3 Pros, 3 Cons

By Tom Taulli, InvestorPlace Contributor
After the spin-off from eBay, PayPal stock has languished. It faces a competitive environment, but remains a trusted global brand.

Examining A Year Of Weak Returns For Diversified Portfolios

By
2015 will be over soon and despite jostling in the stock and bond markets, the net has been very little real gains for diversified portfolios

Analyst: GoPro Inc (GPRO) Stock Has 55% Upside

By John Divine, InvestorPlace Assistant Editor
GoPro (GPRO) stock has been slammed in recent months, but one analyst thinks there's a fortune to be made in these shares.

3 MAJOR Threats to the Facebook Inc (FB) Stock Price

By John Divine, InvestorPlace Assistant Editor
Facebook (FB) stock is riding high after a strong Q3, but ignore these three major risks at your own peril.

Berkshire Hathaway Inc. Earnings DOUBLE, Revenue Misses (BRK)

By John Divine, InvestorPlace Assistant Editor
Berkshire Hathaway (BRK) stock isn't doing much in late trading Friday, despite Q3 earnings doubling to $9.2 billion year-over-year.

Should You Buy Disney (DIS) Stock? 3 Pros, 3 Cons

By Lawrence Meyers, InvestorPlace Contributor
There are plenty of reasons to love Disney, and plenty not to. We explore each side to see whether DIS stock is a buy or not.

Square IPO Prices at $11 – $13, BELOW its Last Private Valuation

By John Divine, InvestorPlace Assistant Editor
The Square IPO price range was announced today, and the mobile payments company will go public for $11 to $13 per share. That's NOT a good sign.

Bass Pro Shops Considers Buying Cabela’s (CAB)

By William White, InvestorPlace Writer
Bass Pro Shops is reportedly considering buying Cabela's, but no financial details of the possible deal have been revealed.

Can Facebook Deliver on All of Its Promises? (FB)

By Charles Payne
Facebook recently surpassed GE in value, and it's "adapt or die" in the markets now ... but can FB deliver on all of its own investments?

DuPont Stock: A Buy Amid Syngenta Talk? (DD, SYT)

By Dan Burrows, InvestorPlace Feature Writer
DuPont's (DD) agriculture division is large and unprofitable, so looking to combine it with a partner like Sygenta or Dow makes good sense.

Fitbit Stock Poised to Rip Higher After Post-Earnings Selloff

By Larry Ramer, InvestorPlace Contributor
Fitbit should benefit from multiple megatrends, and the decline in Fitbit stock after its results was vastly overblown.

FB Stock: The Growth Story Is Just Getting Started

By Louis Navellier, Editor, Growth Investor
FB has found the crucial point of inflection where its tech meets its users' needs.

The Wisdom of Alibaba’s $3.7 Billion Youku Tudou Merger (BABA, YOKU)

By John Divine, InvestorPlace Assistant Editor
Alibaba (BABA) is shelling out $3.7 billion for the 82% of Youku Tudou (YOKU) it doesn't already own. It's a savvy move with precedents in the U.S.

The Pros and Cons of the SEC’s New Crowdfunding Rules

By
The SEC's new rules for equity investing in crowdfunding sites are full of good and bad news for you. Here's what you need to know...

A Look at SPY, Small Caps Suggests It’s Time to Invest Cautiously

By John Jagerson and Wade Hansen
With small caps not growing as robustly as the S&P 500, among other signs, now is a good time to be careful and quicker to take profits.

The Peanuts Movie Reviews: What People Are Saying

By Karl Utermohlen, InvestorPlace Writer
'The Peanuts Movie' is garnering plenty of positive reviews. Here is what people are saying about the Charlie Brown film.

Q3 Earnings: How 5 Top Tech Stocks Stacked Up

By Alyssa Oursler, InvestorPlace Contributor
We grade Google (GOOG, GOOGL), Amazon (AMZN), Apple (AAPL), Twitter (TWTR) and Facebook (FB) on their Q3 earnings results.

Why You Should Believe (and Buy) the Current Rebound in Biotech Stocks

By Hilary Kramer, Editor, GameChangers
Price gouging may have summoned Hillary Clinton's wrath, but the selloff in biotech stocks was built on fearmongering, while the rebound is being built on actual substance.
Load More Articles